Sigma Investment Counselors Inc. Buys 3,828 Shares of Synopsys, Inc. $SNPS

Sigma Investment Counselors Inc. boosted its stake in Synopsys, Inc. (NASDAQ:SNPS) by 18.6% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 24,448 shares of the semiconductor company’s stock after buying an additional 3,828 shares during the quarter. Sigma Investment Counselors Inc.’s holdings in Synopsys were worth $10,633,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. BlackRock Inc. bought a new position in shares of Synopsys in the 2nd quarter worth approximately $7,228,099,000. Van ECK Associates Corp lifted its stake in shares of Synopsys by 19.7% in the 2nd quarter. Van ECK Associates Corp now owns 3,457,249 shares of the semiconductor company’s stock valued at $1,542,175,000 after purchasing an additional 569,687 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Synopsys by 40.7% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,087,349 shares of the semiconductor company’s stock valued at $1,377,174,000 after purchasing an additional 892,736 shares during the period. Assenagon Asset Management S.A. boosted its position in shares of Synopsys by 11.2% during the third quarter. Assenagon Asset Management S.A. now owns 2,729,988 shares of the semiconductor company’s stock valued at $1,187,381,000 after purchasing an additional 274,586 shares in the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Synopsys during the second quarter valued at approximately $747,400,000. 85.47% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

SNPS has been the topic of several recent research reports. Benchmark reaffirmed a “buy” rating and issued a $570.00 price target on shares of Synopsys in a research note on Thursday, August 27th. Roth Capital upgraded Synopsys to a “buy” rating in a report on Friday, September 25th. Weiss Ratings cut shares of Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, September 11th. HSBC cut Synopsys from a “buy” rating to a “reduce” rating in a research note on Friday, September 25th. Finally, Mizuho dropped their target price on shares of Synopsys from $600.00 to $550.00 and set an “outperform” rating on the stock in a research note on Thursday, August 27th. One analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, Synopsys has a consensus rating of “Moderate Buy” and an average price target of $575.00.

Synopsys Stock Up 4.4%

Shares of Synopsys stock opened at $474.42 on Wednesday. Synopsys, Inc. has a 52 week low of $362.55 and a 52 week high of $539.48. The company has a market capitalization of $90.92 billion, a price-to-earnings ratio of 83.82 and a beta of 1.21. The stock’s 50-day simple moving average is $432.75 and its 200-day simple moving average is $444.29.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.67 by $0.24. The firm had revenue of $2.48 billion during the quarter, compared to the consensus estimate of $2.44 billion. The company’s revenue for the quarter was up 42.4% compared to the same quarter last year. During the same period last year, the firm posted $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, equities analysts expect that Synopsys, Inc. will post 11.01 earnings per share for the current year.

Synopsys declared that its Board of Directors has initiated a share buyback program on Monday, October 5th that permits the company to repurchase $1 billion in outstanding shares. This repurchase authorization permits the semiconductor company to repurchase up to 1.1% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s leadership believes its stock is undervalued.

Trending Headlines about Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: SNPS broke above both its 50-day and 200-day moving averages, technical signals that suggest improving short- and long-term momentum and may attract momentum-oriented investors. Synopsys Just Overtook the 50-Day Moving Average Synopsys Just Overtook the 200-Day Moving Average
• Positive Sentiment: S&P raised Synopsys’ credit rating to BBB+, citing its position as a chip-design leader and its ability to benefit from sustained AI-related demand. The upgrade may reinforce confidence in the company’s financial strength and growth prospects. S&P Lifts Synopsys to BBB+
• Positive Sentiment: TetraMem taped out a 12nm AI system-on-chip using Synopsys’ cloud-enabled electronic design automation tools. The development provides a customer-use example supporting demand for Synopsys’ advanced design and simulation software, although it is not expected to have a material immediate financial impact. TetraMem Advances Analog In-Memory Computing
• Positive Sentiment: Analysts’ consensus price target implies substantial potential upside, while commentary highlights Synopsys’ AI agents, chip-design tools and multiphysics simulation as possible drivers of productivity and long-term revenue growth. Can Synopsys’ AI Push Drive Chip Design Efficiency and Growth?
• Neutral Sentiment: Reports discussing SNPS’s long-term investment returns provide historical context but are unlikely to be a major catalyst for the current session. A reported short-interest figure of zero shares also appears unusual and may reflect a data issue rather than a meaningful change in positioning.

Insiders Place Their Bets

In related news, CEO Sassine Ghazi sold 14,604 shares of Synopsys stock in a transaction dated Thursday, October 15th. The shares were sold at an average price of $462.84, for a total transaction of $6,759,315.36. Following the completion of the sale, the chief executive officer owned 76,865 shares in the company, valued at $35,576,196.60. This trade represents a 15.97% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Janet Lee sold 1,144 shares of the stock in a transaction on Tuesday, October 6th. The stock was sold at an average price of $502.52, for a total value of $574,882.88. Following the transaction, the insider directly owned 16,534 shares in the company, valued at $8,308,665.68. The trade was a 6.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 117,163 shares of company stock valued at $51,366,457 over the last quarter. 0.56% of the stock is currently owned by insiders.

Synopsys Company Profile

Synopsys, Inc is an electronic design automation (EDA) and semiconductor intellectual property company serving the global semiconductor and electronics industries. Its software helps engineers design, verify, test and manufacture advanced integrated circuits and electronic systems.

The company’s products and services support digital and analog design, functional verification, design-for-test, manufacturing and semiconductor engineering workflows. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, security solutions and other components used in system-on-chip designs.

In addition to its semiconductor design offerings, Synopsys provides software development and application security tools intended to help organizations identify and manage vulnerabilities and risks across the software development lifecycle.